News & Views
AI Investors Hesitate Despite Market Growth
As the world is facing threats of a major recession in the slipstream of the Covid-19 pandemic, the AI drug development industry is caught ...
Investors Double Down on AI Drug Development
Funding for artificial intelligence in drug development hit $4.1B in 2021, a 36% increase from the year before. The AI drug development industry has ...
Canada’s Early Focus on Artificial Intelligence is Starting to Reap Commercial Benefits
Canada’s early contributions and long-standing expertise in artificial intelligence (AI) have proven valuable when it comes to AI applications in drug development. After several ...
AI Drug Development Market Projected to Reach $5.1 Billion by 2025
The world market for AI applications in drug development is projected to reach $5.1 billion by 2025 with a CAGR of 29.6%, an increase ...
AI Business: AI-based drug development startups have raised $2.1bn in the past six months
Startups that apply AI in drug development have raised a staggering $2.1 billion in H1 this year – with 2021 set to be a ...
The Science Advisory Board: AI drug development startups raised $2.1B in 1st half of 2021
The market for artificial intelligence (AI) in drug development and discovery has been red-hot in recent years. The potential impact that AI can offer ...